1-3 of 3
Michael J. Overman, MD
Close
Sort by
Journal Articles

Long-Term Remissions Of Patients With Follicular Lymphoma Grade 3 Treated With Rituximab, Cyclophospamide, Doxorubicine, Vincristine and Prednisone (R-CHOP)

Paolo Strati, MD, Jorge Enrique Romaguera, MD, Larry W. Kwak, MD, PhD, Fredrick B Hagemeister, MD, Maria Alma Rodriguez, MD, Yasuhiro Oki, MD, Jason R. Westin, MD, Francesco Turturro, MD, Michael J. Overman, MD, Sattva S. Neelapu, MD, Nathan Fowler, MD, Luis Fayad, MD
Journal: Blood
Blood (2013) 122 (21): 3028.
https://doi.org/10.1182/blood.V122.21.3028.3028
Published: 2013
Journal Articles

Randomized Controlled Trial Of Dalteparin For Primary Thromboprophylaxis For Venous Thromboembolism (VTE) In Patients With Advanced Pancreatic Cancer (APC): Risk Factors Predictive Of VTE

Saroj Vadhan-Raj, MD, Xiao Zhou, MD, PhD, Gauri R. Varadhachary, MD, MBBS, Javle Milind, MD, David Fogelman, MD, Rachna Shroff, MD, Carlos E. Bueso-Ramos, MD, PhD, Martin Nguyen, BS, Xuemei Wang, MS, Robert A. Wolff, MD, James L. Abbruzzese, MD, Michael J. Overman, MD
Journal: Blood
Blood (2013) 122 (21): 580.
https://doi.org/10.1182/blood.V122.21.580.580
Published: 2013
Journal Articles

The Addition of Rituximab to CHOP Chemotherapy Improves Response Rate, Failure-Free Survival and Overall Survival for Follicular Grade 3 Lymphoma Compared to CHOP Alone

Michael J. Overman, MD, Lei Feng, MS, Barbara Pro, MD, Peter McLaughlin, MD, Mark Hess, BBA, Felipe Samaniego, MD, Anas Younes, MD, Jorge E. Romaguera, MD, Frederick B. Hagemeister, MD, Larry Kwak, MD, PhD, Fernando Cabanillas, MD, Maria A. Rodriguez, MD, Luis E. Fayad, MD
Journal: Blood
Blood (2007) 110 (11): 1289.
https://doi.org/10.1182/blood.V110.11.1289.1289
Published: 2007